Holen Sie sich die Stockscreener-App
0.834
1.78%
0.0165
Schlusskurs vom Vortag:
$0.8175
Offen:
$0.81
24-Stunden-Volumen:
1.14M
Relative Volume:
0.15
Marktkapitalisierung:
$48.61M
Einnahmen:
$950.10K
Nettoeinkommen (Verlust:
$-16.69M
KGV:
-1.0048
EPS:
-0.83
Netto-Cashflow:
$-15.16M
1W Leistung:
-6.51%
1M Leistung:
-20.00%
6M Leistung:
+4.01%
1J Leistung:
-27.01%
1-Tages-Spanne:
$0.80
$0.86
1-Wochen-Bereich:
$0.7921
$0.9582
52-Wochen-Spanne:
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
Firmenname
Femasys Inc
Sektor
Telefon
770-500-3910
Adresse
3950 JOHNS CREEK COURT, SUWANEE
Vergleichen Sie FEMY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.8313 | 47.81M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
560.62 | 200.96B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
189.12 | 54.09B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.92 | 38.74B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
247.01 | 36.50B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
266.91 | 19.36B | 2.96B | 487.70M | 344.00M | 6.6758 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-20 | Eingeleitet | Laidlaw | Buy |
Femasys Inc Aktie (FEMY) Neueste Nachrichten
FDA Approves Final Trial Phase for Femasys’ Permanent Birth Control Product - Medical Product Outsourcing
PharmaCyte’s Successful Stake Earns them Millions - StocksToTrade
PharmaCyte Boosts Financial Position with Femasys Stake Sale - timothysykes.com
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN
Femasys Inc Stock Analysis and ForecastTechnical Breakout Signals & Minimal Capital Trading - earlytimes.in
CapEx per share of Femasys Inc. – NASDAQ:FEMY - TradingView
Femasys (NASDAQ:FEMY) Rating Increased to Hold at Wall Street Zen - MarketBeat
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
Why Femasys Inc. stock is a must watch in 20252025 Earnings Impact & High Return Trade Guides - BỘ NỘI VỤ
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million - Investing.com Nigeria
PharmaCyte Biotech stock soars after successful Femasys stake sale By Investing.com - Investing.com Australia
PharmaCyte Biotech stock soars after successful Femasys stake sale - Investing.com India
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Lelezard
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million By Investing.com - Investing.com South Africa
PharmaCyte Biotech (Nasdaq: PMCB) Now Holds ~$20M Cash, $25M in Marketable Securities - Stock Titan
Femasys Inc. (FEMY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Femasys (FEMY) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential By Investing.com - Investing.com South Africa
Femasys initiated with a Buy at Laidlaw - TipRanks
Why retail investors pile into Femasys Inc. stockJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com
Is Femasys Inc. stock oversold or undervaluedJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential - Investing.com
Is Femasys Inc. stock attractive for growth ETFsEarnings Summary Report & Safe Capital Growth Stock Tips - newser.com
What margin trends mean for Femasys Inc. stockRate Hike & Fast Exit Strategy with Risk Control - newser.com
Is Femasys Inc. stock affected by interest rate hikesInsider Buying & Verified Entry Point Detection - newser.com
[Form 4] FEMASYS INC Insider Trading Activity - Stock Titan
Applying Elliott Wave Theory to Femasys Inc.2025 Geopolitical Influence & Fast Entry Momentum Alerts - newser.com
Femasys: Strategic Advancements and Financial Health Justify Buy Rating - TipRanks
MSN Money - MSN
Can Femasys Inc. stock reach $100 price targetMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Is Femasys Inc. trending in predictive chart modelsJuly 2025 Levels & Weekly High Momentum Picks - newser.com
Custom watchlist performance reports with Femasys Inc.Earnings Growth Summary & Daily Entry Point Trade Alerts - newser.com
Is Femasys Inc. stock a safe haven assetMarket Performance Report & Reliable Entry Point Alerts - newser.com
Finanzdaten der Femasys Inc-Aktie (FEMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
2.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):